Appili Therapeutics Inc Class A Financial Overview
Appili Therapeutics Inc Class A's market cap is currently C$3.03M. The company's EPS TTM is C$-0.008; its P/E ratio is -1.20; Appili Therapeutics Inc Class A is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
